Your browser doesn't support javascript.
loading
Long COVID: long-term effects?
Di Toro, Alessandro; Bozzani, Antonio; Tavazzi, Guido; Urtis, Mario; Giuliani, Lorenzo; Pizzoccheri, Roberto; Aliberti, Flaminia; Fergnani, Viola; Arbustini, Eloisa.
Afiliación
  • Di Toro A; Department of Medical Sciences and Infectious Diseases, Transplant Research Area and Centre for Inherited Cardiovascular Diseases, Fondazione IRCCS Policlinico San Matteo, Piazzale Camillo Golgi 19, 27100 Pavia, Italy.
  • Bozzani A; Department of Surgical Science, Vascular and Endovascular Surgery Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Tavazzi G; Anaesthesia and Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Urtis M; Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
  • Giuliani L; Department of Medical Sciences and Infectious Diseases, Transplant Research Area and Centre for Inherited Cardiovascular Diseases, Fondazione IRCCS Policlinico San Matteo, Piazzale Camillo Golgi 19, 27100 Pavia, Italy.
  • Pizzoccheri R; Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.
  • Aliberti F; Department of Medical Sciences and Infectious Diseases, Transplant Research Area and Centre for Inherited Cardiovascular Diseases, Fondazione IRCCS Policlinico San Matteo, Piazzale Camillo Golgi 19, 27100 Pavia, Italy.
  • Fergnani V; Department of Medical Sciences and Infectious Diseases, Transplant Research Area and Centre for Inherited Cardiovascular Diseases, Fondazione IRCCS Policlinico San Matteo, Piazzale Camillo Golgi 19, 27100 Pavia, Italy.
  • Arbustini E; Department of Medical Sciences and Infectious Diseases, Transplant Research Area and Centre for Inherited Cardiovascular Diseases, Fondazione IRCCS Policlinico San Matteo, Piazzale Camillo Golgi 19, 27100 Pavia, Italy.
Eur Heart J Suppl ; 23(Suppl E): E1-E5, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34650349
The term Long COVID (or Post COVID) describes a condition characterized by persistence of symptoms for at least 12 weeks after the onset of COVID-19. It may last several months but the duration is still matter of observation. The symptoms and the clinical manifestations are clinically heterogeneous and suggesting involvement of multi-organs/systems, including the cardiovascular system. The general recurrent symptoms include fatigue, breathlessness, myalgia, headache, loss of memory, and impaired concentration. Patients report loss of their previous psychophysical performance. Cardiovascular involvement manifests with common symptoms such as palpitations and chest pain, and, less commonly, with events such as late arterial and venous thromboembolisms, heart failure episodes, strokes or transient ischaemic attack, 'myo-pericarditis'. The diagnostic criteria are mainly based on the narrative of the patients. Measurable biomarkers or instrumental findings or clinical events are not yet framed in a shared diagnostic framework. The open question for clinicians and researchers is whether biomarkers, electrocardiogram, non-invasive imaging, and clinical monitoring should be included in a shared diagnostic protocol aimed at defining the diagnostic path and protecting patients at risk of unexpected events.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Eur Heart J Suppl Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Eur Heart J Suppl Año: 2021 Tipo del documento: Article País de afiliación: Italia